Rankings
▼
Calendar
DNA Q1 2020 Earnings — Ginkgo Bioworks Holdings, Inc. Revenue & Financial Results | Market Cap Arena
DNA
Ginkgo Bioworks Holdings, Inc.
$412M
Q1 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$21M
Gross Profit
$21M
100.0% margin
Operating Income
-$16M
-74.1% margin
Net Income
-$25M
-118.2% margin
EPS (Diluted)
$-0.82
Cash Flow
Operating Cash Flow
-$24M
Free Cash Flow
-$27M
Stock-Based Comp.
$123,000
Balance Sheet
Total Assets
$0
Total Liabilities
$0
Stockholders' Equity
$502M
Cash & Equivalents
-$495M
← FY 2020
All Quarters
Q2 2020 →
